(87 days)
JO Premium Jelly Original Personal Lubricant for penile, anal and/or vaginal application, intended to lubricate and moisturize, to enhance the ease and comfort of intimate sexual activity and supplement the body's natural lubrication. This product is compatible with natural rubber latex, polyurethane and polyisoprene condoms.
JO Premium Jelly Original Personal Lubricant is a clear/water white, viscous gel-type personal lubricant that is compatible with condoms made of natural rubber latex, polyurethane and polyisoprene. This device is a non-sterile personal lubricant for penile, anal and/or vaginal application, to lubricate and moisturize, to enhance the ease and comfort of intimate sexual activity and supplement the body's natural lubrication. This provided in clear, polyethylene (PE) tubes. These 4 oz. size tubes are capped with silver, glossy, polypropylene (PP) flip tops. The individual tubes are hermetically sealed during the production process.
This document describes a 510(k) submission for a personal lubricant and focuses on demonstrating its substantial equivalence to a predicate device. Therefore, it does not involve AI or machine learning, which are typically associated with complex acceptance criteria and studies like MRMC.
Based on the provided document, here's a breakdown of the acceptance criteria and the studies performed, tailored to a medical device rather than an AI product:
1. A table of acceptance criteria and the reported device performance
The acceptance criteria are primarily based on comparisons to the predicate device and established international standards for medical device safety and performance.
| Property | Acceptance Criteria (Specification) | Reported Device Performance |
|---|---|---|
| Appearance | Viscous gel | Viscous gel |
| Color | Clear, water white | Clear, water white |
| Odor | Odorless | Odorless |
| Viscosity (cps) | 1375 cps to 1700 cps | Meets specification (implied by "device met the device specifications at all time points") |
| Specific Gravity | 0.870 to 1.025 | Meets specification (implied by "device met the device specifications at all time points") |
| Antimicrobial effectiveness per USP <51> | Meets USP <51> acceptance criteria for Category 2 products | Meets USP <51> acceptance criteria for Category 2 products |
| Total aerobic microbial count (TAMC) per USP <61> and <1111> | Less than 10 cfu/g | Less than 10 cfu/g |
| Total yeast and mold count (TYMC) per USP <61> and <1111> | Less than 10 cfu/g | Less than 10 cfu/g |
| Presence of Pathogens per USP <62> | Absent (for Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella/Shigella, Escherichia coli, Candida albicans) | Absent (for Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella/Shigella, Escherichia coli, Candida albicans) |
| Biocompatibility | Biocompatible according to ISO 10993 series | Demonstrated to be biocompatible |
| Shelf-Life | 2 years, maintaining all device specifications | 2 years, maintaining all device specifications at 0, 1, and 2 years |
| Condom Compatibility | Compatible with natural rubber latex, polyurethane, and polyisoprene condoms per ASTM D7661-10 | Compatible with natural rubber latex, polyurethane, and polyisoprene condoms |
2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
The document does not specify exact sample sizes for each test in terms of individual units of the lubricant. Instead, it refers to general testing procedures. For biological tests (biocompatibility), typically a minimum number of test units and control units are used as per the specific ISO standards. For chemical/physical property tests, sample sizes are usually defined by the ASTM or USP methods.
The data provenance is from non-clinical performance testing, meaning these were laboratory studies rather than studies on human subjects. The country of origin of the data is not explicitly stated, but the testing was conducted in accordance with international standards (ISO) and U.S. Pharmacopeia (USP) guidelines, implying recognized laboratory practices. These would inherently be prospective studies relative to the testing itself (i.e., new tests performed on the device).
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
This concept of "experts" and "ground truth" to establish a test set is not directly applicable to this type of medical device submission. The "ground truth" here is defined by:
- Established scientific and industry standards (e.g., USP <51>, USP <61>, USP <62>, USP <1111>, ASTM D7661-10, ISO 10993 series).
- The specifications of the predicate device.
The "experts" involved would be qualified laboratory technicians and scientists performing the tests and interpreting results against these objective criteria, rather than clinical experts providing subjective assessments.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Adjudication methods like "2+1" or "3+1" are relevant for clinical studies where subjective assessments (e.g., image interpretation by radiologists) require a consensus mechanism. This is not applicable here as the performance evaluation relies on objective, quantifiable laboratory tests against established standards. Therefore, the adjudication method is none in this context.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
A Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. This type of study is specific to diagnostic aids, particularly those involving human interpretation of data (e.g., medical imaging) and often used to assess the effectiveness of AI assistance. This device is a personal lubricant, and its evaluation does not involve human readers or AI assistance.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
A standalone (algorithm-only) performance study was not applicable or performed, as the device is not an algorithm or AI product.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
The "ground truth" for this device's evaluation is primarily established by:
- International Standards and Pharmacopeia Methods: E.g., ISO 10993 for biocompatibility, USP methods for microbiological analysis, and ASTM D7661-10 for condom compatibility. These standards define the acceptable performance parameters.
- Predicate Device Specifications: The composition and performance characteristics of the legally marketed predicate device (Astroglide Diamond Silicone Gel Personal Lubricant, K163395) serve as a benchmark for substantial equivalence.
8. The sample size for the training set
The concept of a "training set" is relevant for machine learning and AI algorithms. Since this device is a physical product (personal lubricant) and not an AI system, there was no training set used.
9. How the ground truth for the training set was established
As there was no training set, this question is not applicable.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
August 1, 2019
United Consortium Stephanie Morris Global Regulatory Specialist 29000 N. Hancock Pkwy. Valencia. CA 91355
Re: K191214
Trade/Device Name: JO Premium Jelly Original Personal Lubricant Regulation Number: 21 CFR 884.5300 Regulation Name: Condom Regulatory Class: Class II Product Code: NUC Dated: May 3, 2019 Received: May 6, 2019
Dear Stephanie Morris:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
{1}------------------------------------------------
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for
Sharon M. Andrews Assistant Division Director DHT3B: Division of Reproductive. Gynecology and Urology Devices OHT3: Office of Gastrorenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known)
Device Name
JO Premium Jelly Original Personal Lubricant
Indications for Use (Describe)
JO Premium Jelly Original Personal Lubricant for penile, anal and/or vaginal application, intended to lubricate and moisturize, to enhance the ease and comfort of intimate sexual activity and supplement the body's natural lubrication. This product is compatible with natural rubber latex, polyurethane and polyisoprene condoms.
Type of Use (Select one or both, as applicable)Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW *
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regardingthis burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
510 (k) Summary - K191214
1. Submitter Information
| Applicant: | United Consortium |
|---|---|
| Contact: | Stephanie MorrisGlobal Regulatory Specialist |
| Bruce Albert | |
| Head of Technical Services | |
| Address: | 29000 N. Hancock Parkway |
| Valencia, CA 91355 | |
| Phone: | (661) 295-1700, ext. 232 |
| Phone: | (661) 295-1700, ext. 231 |
| FAX: | (661) 295-1800 |
2. Correspondent Information
| Contact: | Stephanie Morris |
|---|---|
| Address: | 29000 N. Hancock ParkwayValencia, CA 91355 |
| Phone: | (661) 295-1700, ext. 232 |
| Fax: | (661) 295-1800 |
| Email: | smorris@systemjo.com |
3. Date prepared: July 30, 2019
4. Device Information
| Device Name: | JO Premium Jelly Original Personal Lubricant |
|---|---|
| Common Name: | Personal Lubricant |
| Regulation Number: | 21 CFR 884.5300 |
| Regulation Name: | Condom |
| Regulatory Class: | Class II |
| Product Code: | NUC (lubricant, personal) |
5. Predicate Device Information
| Device Name: | Astroglide Diamond Silicone Gel Personal Lubricant |
|---|---|
| 510(k) Number: | K163395 |
| Manufacturer: | BioFilm, Inc. |
| Regulatory Class: | Class II |
| Product Code: | NUC (lubricant, personal) |
The predicate device has not been subject to a design-related recall.
6. Device Description
JO Premium Jelly Original Personal Lubricant is a clear/water white, viscous gel-type personal lubricant that is compatible with condoms made of natural rubber latex, polyurethane and polyisoprene. This device is a non-sterile personal lubricant for penile, anal and/or vaginal application, to lubricate and moisturize, to enhance the ease and comfort of intimate sexual activity and supplement the body's natural lubrication. This provided in clear, polyethylene (PE)
{4}------------------------------------------------
tubes. These 4 oz. size tubes are capped with silver, glossy, polypropylene (PP) flip tops. The individual tubes are hermetically sealed during the production process. The device specifications are listed in the table below :
| Table 1: Device Specifications for JO Premium Jelly Original Personal Lubricant | ||||
|---|---|---|---|---|
| -- | -- | -- | -- | --------------------------------------------------------------------------------- |
| Property | Specification |
|---|---|
| Appearance | Viscous gel |
| Color | Clear, water white |
| Odor | Odorless |
| Viscosity (cps) | 1375 cps to 1700 cps |
| Specific Gravity | 0.870 to 1.025 |
| Antimicrobial effectiveness per USP <51> | Meets US <51> acceptance criteria for Category 2 products |
| Total aerobic microbial count (TAMC) per USP <61> and <1111> | Less than 10 cfu/g |
| Total yeast and mold count (TYMC) per USP <61> and <1111> | Less than 10 cfu/g |
| Presence of Pathogens per USP <62> | Specification |
| Pseudomonas aeruginosa | Absent |
| Staphylococcus aureus | Absent |
| Salmonella/Shigella | Absent |
| Escherichia coli | Absent |
| Candida albicans | Absent |
7. Indications for Use
JO Premium Jelly Original Personal Lubricant is a personal lubricant for penile, anal and/or vaginal application, intended to lubricate and moisturize, to enhance the ease and comfort of intimate sexual activity and supplement the body's natural lubrication. This product is compatible with natural rubber latex, polyurethane and polyisoprene condoms.
8. Comparison of Intended Use and Technological Characteristics with the Predicate Device
The table below lists the comparative indications for use and technological characteristics of the subject and predicate device.
Table 2: Comparator Table for Subject Device - JO Premium Jelly Original Personal Lubricant and Predicate Device Astroglide Diamond Silicone Gel Personal Lubricant
| Feature | JO Premium JellyOriginal PersonalLubricant | Astroglide DiamondSilicone Gel PersonalLubricant (K163395) |
|---|---|---|
| Device ClassificationName | Lubricant, Personal | Lubricant, Personal |
| Product Code | NUC | NUC |
{5}------------------------------------------------
| Feature | JO Premium JellyOriginal PersonalLubricant | Astroglide DiamondSilicone Gel PersonalLubricant (K163395) |
|---|---|---|
| Indications for Use | JO Premium Jelly OriginalPersonal Lubricant is apersonal lubricant for penile,anal and/or vaginal application,intended to lubricate andmoisturize, to enhance the easeand comfort of intimate sexualactivity and supplement thebody's natural lubrication. Thisproduct is compatible withnatural rubber latex,polyurethane and polyisoprenecondoms. | Astroglide® Diamond SiliconeGel Personal Lubricant is apersonal lubricant for penileand/or vaginal application,intended to moisturize andlubricate, to enhance the easeand comfort of intimate sexualactivity and supplement thebody's natural lubrication. Thisproduct is compatible withnatural rubber latex,polyurethane andpolyisoprene condoms. |
| Water soluble | No | No |
| Contains water | No | No |
| Primary ingredients | Dimethicone,Cyclopentasiloxane,Cyclotetrasiloxane, Dimethicone/ Vinyl DimethiconeCrosspolymer, Dimethiconol | Dimethicone, CyclomethiconeDimethicone / VinylDimethicone Crosspolymer,Cocos Nucifera (Coconut) Oil |
| Over the counter use | Yes | Yes |
| Sterile | No | No |
| Condom Compatibility | Natural Rubber Latex,Polyurethane, Polyisoprene | Natural Rubber Latex,Polyurethane, Polyisoprene |
| Biocompatibility Tested | Yes | Yes |
| Antimicrobial Tested | Yes | Yes |
| Shelf life | 2 years | 2 years |
The subject and predicate device have similar indications for use. The indication for the subject device has been expanded to also include anal use. This change does not represent a new intended use as the intended use of this device is the same as the predicate device, i.e., lubrication of an orifice during intimate sexual activity. The subject and predicate device have similar technological characteristics, including similar formulation. The different technological characteristics of the subject device do not raise different types of safety and effectiveness questions.
9. Summary of Non-Clinical Performance Testing
Biocompatibility
Biocompatibility studies, including Acute Systemic Toxicity, Vaginal Irritation Testing, Penile Irritation Testing, Cytotoxicity and Sensitization testing were performed in accordance with the 2016 FDA guidance document Use of International Standard ISO 10993-1, "Biological Evaluation of Medical Devices - Part 1: Evaluation and testing within a risk management process" and ISO 10993- 1:2009 as follows:
- Cytotoxicity (ISO 10993-5:2009)
- Sensitization (ISO 10993-10:2010)
- . Vaginal Irritation (ISO 10993-10:2010)
{6}------------------------------------------------
- Penile Irritation (ISO 10993-10:2010) ●
- Acute Systemic Toxicity (ISO 10993-11:2006) ●
The results of this testing demonstrated that the subject lubricant is biocompatible.
Shelf-Life
The subject device is a non-sterile personal lubricant with a two-year shelf-life in accordance with the results of a real time and accelerated aging study. All device specifications listed in Table 1 were tested at 0, 1 and 2 years. The subject device met the device specifications at all time points.
Condom Compatibility
The compatibility of the subject device with natural rubber latex, polyisoprene and polyurethane condoms was evaluated in accordance with ASTM D7661-10 Standard Test Method for Determining Compatibility of Personal Lubricants with Natural Rubber Latex Condoms. The results of this test indicated that JO Premium Jelly Original Personal Lubricant is compatible with natural rubber latex, polyurethane and polyisoprene condoms.
10. Conclusion
The results of the performance testing described above demonstrate that the JO Premium Jelly Original Personal Lubricant is as safe and effective as the predicate device and supports a determination of substantial equivalence.
§ 884.5300 Condom.
(a)
Identification. A condom is a sheath which completely covers the penis with a closely fitting membrane. The condom is used for contraceptive and for prophylactic purposes (preventing transmission of sexually transmitted infections). The device may also be used to collect semen to aid in the diagnosis of infertility.(b)
Classification. (1) Class II (special controls) for condoms made of materials other than natural rubber latex, including natural membrane (skin) or synthetic.(2) Class II (special controls) for natural rubber latex condoms. The guidance document entitled “Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300” will serve as the special control. See § 884.1(e) for the availability of this guidance document.